GENENTECH AND CGI PHARMACEUTICALS ENTER INTO EXCLUSIVE GLOBAL STRATEGIC ALLIANCE FOR POTENTIAL PRODUCTS IN MULTIPLE ONCOLOGY AND AUTOIMMUNE INDICATIONS

Genentech, Inc. and CGI Pharmaceuticals, Inc. announced that they have entered into an exclusive global collaboration agreement to discover, develop, manufacture and commercialize therapeutics for an undisclosed target for the potential treatment of multiple oncology and autoimmune indications.

Yahoo Finance (http://biz.yahoo.com/prnews/061003/sftu111.html?.v=61)